Biosecurity-Aware AI: Agentic Risk Auditing of Soft Prompt Attacks on ESM-Based Variant Predictors
Huixin Zhan
TL;DR
Genomic foundation models enable broad, zero-shot variant effect prediction but raise security concerns as adversarial inputs can shift predictions. The authors introduce SAGE, an agentic auditing framework that perturbs embeddings through soft prompts, monitors responses across training checkpoints, and uses AUROC/AUPR plus LLM-generated explanations to assess robustness without altering model weights. Experiments show targeted soft prompt attacks degrade performance across multiple GFMs and disease datasets, with smaller models being more vulnerable and robustness varying by architecture. The layered OBSERVE-INTERVENE-EVALUATE-REASON-REPORT pipeline demonstrates interpretable, reproducible risk auditing, offering a practical path to safer deployment of genomic AI in clinical settings.
Abstract
Genomic Foundation Models (GFMs), such as Evolutionary Scale Modeling (ESM), have demonstrated remarkable success in variant effect prediction. However, their security and robustness under adversarial manipulation remain largely unexplored. To address this gap, we introduce the Secure Agentic Genomic Evaluator (SAGE), an agentic framework for auditing the adversarial vulnerabilities of GFMs. SAGE functions through an interpretable and automated risk auditing loop. It injects soft prompt perturbations, monitors model behavior across training checkpoints, computes risk metrics such as AUROC and AUPR, and generates structured reports with large language model-based narrative explanations. This agentic process enables continuous evaluation of embedding-space robustness without modifying the underlying model. Using SAGE, we find that even state-of-the-art GFMs like ESM2 are sensitive to targeted soft prompt attacks, resulting in measurable performance degradation. These findings reveal critical and previously hidden vulnerabilities in genomic foundation models, showing the importance of agentic risk auditing in securing biomedical applications such as clinical variant interpretation.
